Want a deeper scan?
Get a guided tour of your organization’s security posture from an UpGuard team member.

Alimera Sciences

This is a preliminary report on Alimera Sciences’s security posture. If you want in-depth, always up-to-date reports on Alimera Sciences and millions of other companies, start a free trial today. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.
Get the full report

UpGuard Security Rating

/ 950
This is a 0-950 security rating for Alimera Sciences. The higher the rating, the more likely Alimera Sciences has good security practices. For complete visibility of the security posture of Alimera Sciences, start a free trial of UpGuard.

Company info

Alimera Sciences
Alimera Sciences
Alpharetta, GA, United States.
Last updated
Last updated
Last updated today

Security report for Alimera Sciences

Alimera Sciences, Inc. is a biopharmaceutical company based in Alpharetta, Georgia that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Get the full report
Last updated today

Alimera Sciences Data Breaches and Security News

Relevant news, breaches and security articles relating to Alimera Sciences.

More security reports

Compare Alimera Sciences's security performance with other companies.

Leader in Third Party & Supplier Risk Management Software

See how UpGuard shapes up against other platforms in the market.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating
Want a full vendor security report for this company?
Start your free trial and unlock real-time insights to identify and assess vendor risks.